{"name": "Concert Pharmaceuticals",
 "permalink": "concert-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/concert-pharmaceuticals",
 "homepage_url": "http://www.concertpharma.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2006,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@concertpharma.com",
 "phone_number": "781.860.0045",
 "description": "Biotechnology company",
 "created_at": "Tue May 26 06:20:33 UTC 2009",
 "updated_at": "Tue Aug 28 20:20:54 UTC 2012",
 "overview": "\u003Cp\u003EFounded in April 2006, Concert Pharmaceuticals is a clinical stage biotechnology company dedicated to creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium.\u003C/p\u003E\n\n\u003Cp\u003EConcert applies its innovative precision deuterium chemistry platform to modify specific properties of validated drug molecules, yielding a rich pipeline of new chemical entities (NCEs). Concert leverages decades of pharmaceutical experience to create novel drug candidates with potential for best-in-class efficacy and safety, while greatly reducing R\u0026amp;D risk, time and expense.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       43],
      "assets/images/resized/0004/5452/45452v1-max-150x150.jpg"],
     [[180,
       52],
      "assets/images/resized/0004/5452/45452v1-max-250x250.jpg"],
     [[180,
       52],
      "assets/images/resized/0004/5452/45452v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Roger",
      "last_name": "Tung",
      "permalink": "roger-tung",
      "image": null}},
   {"is_past": false,
    "title": "Chief Business Officer",
    "person":
     {"first_name": "Steve",
      "last_name": "Bernitz",
      "permalink": "steve-bernitz",
      "image": null}},
   {"is_past": false,
    "title": "Vice President and General Counsel",
    "person":
     {"first_name": "Robert",
      "last_name": "Silverman",
      "permalink": "robert-silverman",
      "image": null}},
   {"is_past": false,
    "title": "COO",
    "person":
     {"first_name": "Nancy",
      "last_name": "Stuart",
      "permalink": "nancy-stuart",
      "image": null}},
   {"is_past": false,
    "title": "Vice President, Drug Development",
    "person":
     {"first_name": "Robert",
      "last_name": "Zelle",
      "permalink": "robert-zelle",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$99.5M",
 "funding_rounds":
  [{"round_code": "c",
    "source_url": "",
    "source_description": "Capital Funding Report",
    "raised_amount": 37000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2008,
    "funded_month": 4,
    "funded_day": 30,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "QVT Financial",
         "permalink": "qvt-financial",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0004/5453/45453v1-max-150x150.png"],
             [[153,
               44],
              "assets/images/resized/0004/5453/45453v1-max-250x250.png"],
             [[153,
               44],
              "assets/images/resized/0004/5453/45453v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "GSK Venture Fund",
         "permalink": "gsk-venture-fund",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Mediphase Venture Partners",
         "permalink": "mediphase-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               77],
              "assets/images/resized/0003/2809/32809v1-max-150x150.png"],
             [[170,
               88],
              "assets/images/resized/0003/2809/32809v1-max-250x250.png"],
             [[170,
               88],
              "assets/images/resized/0003/2809/32809v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Westfield Capital Management",
         "permalink": "westfield-capital-management",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0004/5458/45458v1-max-150x150.jpg"],
             [[250,
               60],
              "assets/images/resized/0004/5458/45458v1-max-250x250.jpg"],
             [[273,
               66],
              "assets/images/resized/0004/5458/45458v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Three Arch Partners",
         "permalink": "three-arch-partners",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0003/0743/30743v1-max-150x150.png"],
             [[230,
               80],
              "assets/images/resized/0003/0743/30743v1-max-250x250.png"],
             [[230,
               80],
              "assets/images/resized/0003/0743/30743v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Skyline Ventures",
         "permalink": "skyline-ventures",
         "image":
          {"available_sizes":
            [[[150,
               53],
              "assets/images/resized/0025/1697/251697v1-max-150x150.png"],
             [[250,
               88],
              "assets/images/resized/0025/1697/251697v1-max-250x250.png"],
             [[300,
               106],
              "assets/images/resized/0025/1697/251697v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "TVM Capital",
         "permalink": "tvm-capital",
         "image":
          {"available_sizes":
            [[[150,
               35],
              "assets/images/resized/0003/0797/30797v1-max-150x150.png"],
             [[221,
               53],
              "assets/images/resized/0003/0797/30797v1-max-250x250.png"],
             [[221,
               53],
              "assets/images/resized/0003/0797/30797v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Brookside Capital",
         "permalink": "brookside-capital",
         "image":
          {"available_sizes":
            [[[150,
               18],
              "assets/images/resized/0000/3991/3991v1-max-150x150.png"],
             [[200,
               24],
              "assets/images/resized/0000/3991/3991v1-max-250x250.png"],
             [[200,
               24],
              "assets/images/resized/0000/3991/3991v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "New Leaf Venture Partners",
         "permalink": "new-leaf-venture-partners-2",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0004/2730/42730v1-max-150x150.png"],
             [[250,
               66],
              "assets/images/resized/0004/2730/42730v1-max-250x250.png"],
             [[257,
               68],
              "assets/images/resized/0004/2730/42730v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Flagship Ventures",
         "permalink": "flagship-ventures",
         "image":
          {"available_sizes":
            [[[150,
               34],
              "assets/images/resized/0002/8188/28188v4-max-150x150.png"],
             [[250,
               57],
              "assets/images/resized/0002/8188/28188v4-max-250x250.png"],
             [[323,
               74],
              "assets/images/resized/0002/8188/28188v4-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Adage Capital Management",
         "permalink": "adage-capital-management",
         "image":
          {"available_sizes":
            [[[150,
               13],
              "assets/images/resized/0004/6501/46501v1-max-150x150.jpg"],
             [[250,
               23],
              "assets/images/resized/0004/6501/46501v1-max-250x250.jpg"],
             [[422,
               39],
              "assets/images/resized/0004/6501/46501v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Greylock Partners",
         "permalink": "greylock",
         "image":
          {"available_sizes":
            [[[150,
               35],
              "assets/images/resized/0000/4363/4363v3-max-150x150.jpg"],
             [[250,
               59],
              "assets/images/resized/0000/4363/4363v3-max-250x250.jpg"],
             [[450,
               107],
              "assets/images/resized/0000/4363/4363v3-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://concertpharma.com/news/2006_1130.html",
    "source_description": "Concert Pharmaceuticals Raises $48.5 Million in Series B Financing",
    "raised_amount": 48500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 11,
    "funded_day": 30,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Flagship Ventures",
         "permalink": "flagship-ventures",
         "image":
          {"available_sizes":
            [[[150,
               34],
              "assets/images/resized/0002/8188/28188v4-max-150x150.png"],
             [[250,
               57],
              "assets/images/resized/0002/8188/28188v4-max-250x250.png"],
             [[323,
               74],
              "assets/images/resized/0002/8188/28188v4-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Brookside Capital",
         "permalink": "brookside-capital",
         "image":
          {"available_sizes":
            [[[150,
               18],
              "assets/images/resized/0000/3991/3991v1-max-150x150.png"],
             [[200,
               24],
              "assets/images/resized/0000/3991/3991v1-max-250x250.png"],
             [[200,
               24],
              "assets/images/resized/0000/3991/3991v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "New Leaf Venture Partners",
         "permalink": "new-leaf-venture-partners-2",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0004/2730/42730v1-max-150x150.png"],
             [[250,
               66],
              "assets/images/resized/0004/2730/42730v1-max-250x250.png"],
             [[257,
               68],
              "assets/images/resized/0004/2730/42730v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Three Arch Partners",
         "permalink": "three-arch-partners",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0003/0743/30743v1-max-150x150.png"],
             [[230,
               80],
              "assets/images/resized/0003/0743/30743v1-max-250x250.png"],
             [[230,
               80],
              "assets/images/resized/0003/0743/30743v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "TVM Capital",
         "permalink": "tvm-capital",
         "image":
          {"available_sizes":
            [[[150,
               35],
              "assets/images/resized/0003/0797/30797v1-max-150x150.png"],
             [[221,
               53],
              "assets/images/resized/0003/0797/30797v1-max-250x250.png"],
             [[221,
               53],
              "assets/images/resized/0003/0797/30797v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Skyline Ventures",
         "permalink": "skyline-ventures",
         "image":
          {"available_sizes":
            [[[150,
               53],
              "assets/images/resized/0025/1697/251697v1-max-150x150.png"],
             [[250,
               88],
              "assets/images/resized/0025/1697/251697v1-max-250x250.png"],
             [[300,
               106],
              "assets/images/resized/0025/1697/251697v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Greylock Partners",
         "permalink": "greylock",
         "image":
          {"available_sizes":
            [[[150,
               35],
              "assets/images/resized/0000/4363/4363v3-max-150x150.jpg"],
             [[250,
               59],
              "assets/images/resized/0000/4363/4363v3-max-250x250.jpg"],
             [[450,
               107],
              "assets/images/resized/0000/4363/4363v3-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "QVT Financial",
         "permalink": "qvt-financial",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0004/5453/45453v1-max-150x150.png"],
             [[153,
               44],
              "assets/images/resized/0004/5453/45453v1-max-250x250.png"],
             [[153,
               44],
              "assets/images/resized/0004/5453/45453v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "a",
    "source_url": "http://concertpharma.com/news/2006_0717.html",
    "source_description": "Concert Pharmaceuticals, Inc.,\u00e2\u201e\u00a2 Announces Financing of its Series A Round",
    "raised_amount": 10000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 7,
    "funded_day": 17,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Three Arch Partners",
         "permalink": "three-arch-partners",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0003/0743/30743v1-max-150x150.png"],
             [[230,
               80],
              "assets/images/resized/0003/0743/30743v1-max-250x250.png"],
             [[230,
               80],
              "assets/images/resized/0003/0743/30743v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "TVM Capital",
         "permalink": "tvm-capital",
         "image":
          {"available_sizes":
            [[[150,
               35],
              "assets/images/resized/0003/0797/30797v1-max-150x150.png"],
             [[221,
               53],
              "assets/images/resized/0003/0797/30797v1-max-250x250.png"],
             [[221,
               53],
              "assets/images/resized/0003/0797/30797v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Skyline Ventures",
         "permalink": "skyline-ventures",
         "image":
          {"available_sizes":
            [[[150,
               53],
              "assets/images/resized/0025/1697/251697v1-max-150x150.png"],
             [[250,
               88],
              "assets/images/resized/0025/1697/251697v1-max-250x250.png"],
             [[300,
               106],
              "assets/images/resized/0025/1697/251697v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Greylock Partners",
         "permalink": "greylock",
         "image":
          {"available_sizes":
            [[[150,
               35],
              "assets/images/resized/0000/4363/4363v3-max-150x150.jpg"],
             [[250,
               59],
              "assets/images/resized/0000/4363/4363v3-max-250x250.jpg"],
             [[450,
               107],
              "assets/images/resized/0000/4363/4363v3-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "QVT Financial",
         "permalink": "qvt-financial",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0004/5453/45453v1-max-150x150.png"],
             [[153,
               44],
              "assets/images/resized/0004/5453/45453v1-max-250x250.png"],
             [[153,
               44],
              "assets/images/resized/0004/5453/45453v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.masshightech.com/stories/2011/06/20/daily1-Concert-Pharmaceuticals-lands-4M-milestone-pay.html",
    "source_description": "Concert Pharmaceuticals lands $4M milestone pay",
    "raised_amount": 4000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 6,
    "funded_day": 20,
    "investments":
     [{"company":
        {"name": "GlaxoSmithKline",
         "permalink": "glaxosmithkline",
         "image":
          {"available_sizes":
            [[[150,
               51],
              "assets/images/resized/0005/1020/51020v1-max-150x150.png"],
             [[158,
               54],
              "assets/images/resized/0005/1020/51020v1-max-250x250.png"],
             [[158,
               54],
              "assets/images/resized/0005/1020/51020v1-max-450x450.png"]],
           "attribution": null}},
       "financial_org": null,
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "Corporate Headquarters",
    "address1": "99 Hayden Avenue",
    "address2": "Suite 500",
    "zip_code": "02421",
    "city": "Lexington",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": 42.4236783,
    "longitude": -71.2459523}],
 "milestones":
  [{"description": "Concert Pharmaceuticals to land $12M from HIV drug's clinical study",
    "stoned_year": 2009,
    "stoned_month": 11,
    "stoned_day": 9,
    "source_url": "http://www.masshightech.com/stories/2009/11/09/daily10-Concert-Pharmaceuticals-to-land-12M-from-HIV-drugs-clinical-study.html",
    "source_text": "",
    "source_description": "Mass High Tech",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Concert Pharmaceuticals",
      "permalink": "concert-pharmaceuticals"}},
   {"description": "Concert Pharmaceuticals, Walter Reed partner on seizure teatment",
    "stoned_year": 2011,
    "stoned_month": 2,
    "stoned_day": 2,
    "source_url": "http://www.masshightech.com/stories/2011/01/31/daily28-Concert-Pharmaceuticals-Walter-Reed-partner-on-seizure-teatment.html",
    "source_text": "",
    "source_description": "Concert Pharmaceuticals, Walter Reed partner on seizure teatment",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Concert Pharmaceuticals",
      "permalink": "concert-pharmaceuticals"}},
   {"description": "has made two new executive appointments",
    "stoned_year": 2011,
    "stoned_month": 4,
    "stoned_day": 12,
    "source_url": "http://www.masshightech.com/stories/2011/04/11/daily27-Concert-Pharmaceuticals-names-Roessel-Sabounjian-to-exec-roles.html",
    "source_text": null,
    "source_description": "Concert Pharmaceuticals names Roessel, Sabounjian to exec roles",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Concert Pharmaceuticals",
      "permalink": "concert-pharmaceuticals"}},
   {"description": "Concert Pharma snags $200M licensing pact with Avanir",
    "stoned_year": 2012,
    "stoned_month": 2,
    "stoned_day": 29,
    "source_url": "http://www.fiercebiotech.com/story/concert-pharma-snags-200m-licensing-pact-avanir/2012-02-29?utm_medium=rss\u0026utm_source=rss",
    "source_text": "",
    "source_description": "Concert Pharma snags $200M licensing pact with Avanir",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Concert Pharmaceuticals",
      "permalink": "concert-pharmaceuticals"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        82],
       "assets/images/resized/0004/5451/45451v1-max-150x150.jpg"],
      [[250,
        137],
       "assets/images/resized/0004/5451/45451v1-max-250x250.jpg"],
      [[450,
        246],
       "assets/images/resized/0004/5451/45451v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}